These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 22019659)

  • 41. [Guillain-Barré syndrome in childhood].
    Kollár K; Liptai Z; Rosdy B; Móser J
    Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and electrophysiological features of the 2007 Guillain-Barré syndrome epidemic in northeast China.
    Ye Y; Zhu D; Wang K; Wu J; Feng J; Ma D; Xing Y; Jiang X
    Muscle Nerve; 2010 Sep; 42(3):311-4. PubMed ID: 20589890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.
    Uncini A; Kuwabara S
    Clin Neurophysiol; 2012 Aug; 123(8):1487-95. PubMed ID: 22480600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile.
    Yuki N; Kuwabara S; Koga M; Hirata K
    J Neurol Sci; 1999 Oct; 168(2):121-6. PubMed ID: 10526194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Electrophysiological subtypes and long term prognosis of Guillain-Barré syndrome].
    Zhang J; Song XJ; Hou HQ; Tan GJ; Bian GY; Li B; Chen LP; Wang L; Guo L
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):1987-90. PubMed ID: 27470955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Electrophysiological subtypes of Guillain-Barré syndrome in Mexican adults].
    Zúñiga-González EA; Rodríguez-de la Cruz A; Millán-Padilla J
    Rev Med Inst Mex Seguro Soc; 2007; 45(5):463-8. PubMed ID: 18294437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.
    Kuwabara S; Bostock H; Ogawara K; Sung JY; Kanai K; Mori M; Hattori T; Burke D
    Muscle Nerve; 2003 Dec; 28(6):683-9. PubMed ID: 14639581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
    Rajabally YA; Hassan-Smith G; Notturno F; Eames PJ; Hayton T; Capasso M; Uncini A
    J Neurol Sci; 2011 Apr; 303(1-2):35-8. PubMed ID: 21316711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N; Kuwabara S
    J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guillain-barré syndrome.
    Kuwabara S
    Curr Neurol Neurosci Rep; 2007 Jan; 7(1):57-62. PubMed ID: 17217855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel.
    Kushnir M; Klein C; Pollak L; Rabey JM
    Acta Neurol Scand; 2008 May; 117(5):347-50. PubMed ID: 17995988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
    Ho TW; Willison HJ; Nachamkin I; Li CY; Veitch J; Ung H; Wang GR; Liu RC; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
    Ann Neurol; 1999 Feb; 45(2):168-73. PubMed ID: 9989618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serologic marker of acute motor axonal neuropathy in childhood.
    Nishimoto Y; Susuki K; Yuki N
    Pediatr Neurol; 2008 Jul; 39(1):67-70. PubMed ID: 18555178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
    Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
    Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.